Toxoplasma Infection in Schizophrenia Patients: A Comparative Study with Control Group
Abstract
Background: Schizophrenia is a serious, chronic, and often debilitating neuropsychiatric disorder. Its causes are still poorly understood. Besides genetic and non-genetic (environmental) factors are thought to be important as the cause of the structural and functional deficits that characterize schizophrenia. This study aimed to compare Toxoplasma gondii infection between schizophrenia patients and non-schizophrenia individuals as control group.
Methods: A case-control study was designed in Tehran, Iran during 2009-2010. Sixty-two patients with schizophrenia and 62 non-schizophrenia volunteers were selected. To ascertain a possible relationship between T. gondii infection and schizophrenia, anti-Toxoplasma IgG antibodies were detected by indirect-ELISA. Data were statistically analyzed by chi- square at a confidence level of 99%.
Results: The sero-positivity rate among patients with schizophrenia (67.7%) was significantly higher than control group (37.1) (P <0. 01).
Conclusion: A significant correlation between Toxoplasma infection and schizophrenia might be expected.
Dubey JP. Toxoplasmosis of Animals and Humans. Second edition. CRC Press; 2010, 313.
Carruthers VB, Suzuki Y. Effect of Toxoplasma gondii Infection on the Brain. SchizopherBull. 2007:33:745-51.
Wang HL, Wang GH, LiQ Y, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma seropositive and Toxoplasma seronegative schizophrenia. Acta PsychiatrScand. 2006:40-8.
Flegr J, Zitkova S, Kodym P, Frynta D. Induction of changes in human behavior by the parasitic protozoan Toxoplasma gondii.Parasitol. 1996;113:49–54.
Flegr J, Kodym P, Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes inwomen. BiolPsychol.2000;53:57–68.
Holliman RE. Toxoplasmosis, behavior, and personality.J Infect.1997;35:105–10.
Havlicek J, Gasova Z, Smith AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent asymptomatic tox-oplasmosis. Parasitol.n2001;122:515–20.
Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cat? Schizophr Bull. 1995; 21:167–71.
Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. AmJ Psychiatry. 2005;162:767–73.
Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case–control study of selected risk factors. Schizophr Res.2000;46:17–23.
Delgado GG, Garcia LJ. Reactivity of the intradermal test with toxoplasmosis in schizophrenic patients. Rev CubanaMed Trop. 1979;31:225–31.
Li QY, Luo XN, Li L, Tong F. Comparative study on Toxoplasma infection in patients with schizophrenia and affective disorder. Med J Wuhan Univ (Chinese). 1999;20:222–3.
Gu H, Yolken RH, Phillips M et al. Evidence of Toxoplasma gondii infection in recent-onset schizophrenia (abstract). Schizophr Res.2001;49:53.
Yolken RH, Bachmann S,Rouslanova I et al. Antibodies to Toxoplasma gondii in ind-ividuals with first-episode schizophrenia. Clin InfectDis. 2001;32:842–44.
Leweke FM, Gerth CW, Koethe D et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:4–8.
Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii.mSchizophr Res.2003.62 (3),237–44.
Torrey EF, Yolken RH. Toxoplasma gondii and Schizophrenia. Emerg Infect Dis. 2003;9:1375–80.
Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia— preliminary fin-dings in a Turkish sample. Schizophr Bull. Advance Access April2, 2007.
Johnstone A, Thorpe R. Immunochemistry in practice. 3rd ed. London: Blackwell Science;1996.
Johnson JD, Holliman RE. Toxoplasmosis. In: Gillespie SH. Hawkey PM(Eds). Medical Parasitology practical approach. 1st ed. New york: Oxford university press;1995.
Powell HC, Gibbs CJ Jr, Lorenzo AM, Lampert PW, Gajdusek DC. Toxoplasmosis of the central nervous system in the adult. Electron microscopic observations. Acta Neuropathol (Berl). 1978;41:211–6.
Bertoli F, Espino M, Arosemena JR, Fishback JL, Frenkel JK. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1995;119:214–24.
Ghatak NR, Zimmerman HM. Fine structure of Toxoplasma in the human brain. Arch Pathol. 1973;95:276–83.
Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. BrainResBull.2001;55:585–95.
Doyle C, Deakin JFW. Fewer astrocytes in frontal cortex in schizophrenia, depression and bipolar disorder [abstract]. Schizophr Res.2002;53:106.
Sims TS, Hay J. Host-parasite relationship between congenital Toxoplasma infection and mouse brain: role of small vessels. Parasitology. 1995;110:123–7.
Torrey EF, Bartko jj, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: A Meta- Analysis. Schizophr Bull.2007:33:729-36.
Torrey EF. Are we overestimating the genetic contribution to schizophrenia? Schizo-phrBull. 1992;18:159–170.
Saraei-Sahnesaraei M, Shamloo F, Jahani Hashemi H, Khabbaz F, Alizadeh SA. Relation Between Toxoplasma gondii Infections and Schizophrenia. Iranian J PsychaitrClin Psychol. 2009;15 (1) :3-9.
Boks MPM, Liddle PF, Burgerhof JGM, Knegtering R, Van den Bosch R-J. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr Scand. 2004; 110:29–35.
Hill K, Mann L, Laws KR, Stephenson CME, Nimmo-Smith I, McKenna PJ. Hypofrontality in schizophrenia: a metaanalysis of functional imaging studies. Acta Psychiatr Scand. 2004;110:243–56.
Files | ||
Issue | Vol 6 No 2 (2011) | |
Section | Articles | |
Keywords | ||
Schizophrenia Toxoplasma gondii ELISA Iran |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |